Johnson & Johnson vs Stryker Corporation — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
7.5
Bullish
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
SYK
Consensus analyst target of $394.12 is 34% above current price.
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $394.12 (+33.7%)
26 analysts
Fundamentals
JNJ
SYK
26.3×
Trailing P/E
35.1×
17.9×
Forward P/E
17.6×
21.8%
Profit Margin
13.2%
68.0%
Gross Margin
64.7%
26.4%
ROE
15.2%
9.9%
Revenue Growth
2.6%
-52.9%
Earnings Growth
14.2%
0.33
Beta
0.93
—
Price / Book
—
$546.9B
Market Cap
$112.9B
$146 – $252
52-Week Range
$295 – $405
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →